Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 292, Issue 3, 2007, Pages

  Borthakur, Alip ^a   Bhattacharyya, Sumit ^a   Dudeja, Pradeep K ^a   Tobacman, Joanne K ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Colon; I B ; Inflammation; NF B

Indexed keywords

CARRAGEENAN; COMPLEMENTARY DNA; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PROTEIN BCL 10; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL LINE; COLON MUCOSA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA MICROARRAY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CAFFEIC ACIDS; CARRAGEENAN; CELL LINE; CELLS, CULTURED; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-8; INTESTINAL MUCOSA; MODELS, BIOLOGICAL; NF-KAPPA B; PHENYLETHYL ALCOHOL; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); RATS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 33947331528     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00380.2006     Document Type: Article

References (43)

1. Baeuerle PA. Iκ-NF-κB structures: at the interface of inflammation control. Cell 95: 729-731, 1998.
2. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
3. Bonizzi G, Karin M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25: 280-288, 2004.
4. Calvert RJ, Reicks M. Alterations in colonic thymidine kinase enzyme activity induced by consumption of various dietary fibers. Proc Soc Exp Biol Med 189: 45-51, 1988.
5. Corpet DE, Taché S, Préclaire M. Carrageenan given as a jelly, does not initiate, but promotes the growth of aberrant crypt foci in the rat colon. Cancer Lett 114: 53-55, 1997.
6. Costanzo A, Guiet C, Vito P. c-E10 is a caspase-recruitment domain-containing protein that interacts with components of death receptors signaling pathway and activates NF-κB. J Biol Chem 274: 20127-20132, 1999.
7. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Ciccolo A, Centorrino T, De Sarro A, Caputi AP. Protective effects of n-acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat. FASEB J 15: 1187-1192, 2001.
8. European Commission Scientific Committee on Food. Opinion of the Scientific Committee on food on carrageenan: report of the European Commission health and consumer protection directorate-general, March 5, 2003.
9. 1 mice. Digestion 29: 197-293, 1984.
10. Fiocchi C. Intestinal inflammation: a complex interplay of immune and non-immune cell interactions. Am J Physiol Gastrointest Liver Physiol 273: G769-G775, 1997.
11. Guiet C, Vito P. Caspase recruitment domain (CARD)-dependent cytoplasmic filaments mediate Bcl10 induced NF-κB activation. J Biol Chem 148: 1131-1140, 2000.
12. Hadjiagapiou C, Borthakur A, Dahdal RY, Gill RK, Malakooti J, Ramaswamy K, Dudeja PK. Role of USF1 and USF2 as potential repressor proteins for human intestinal monocarboxylate transporter 1 promoter. Am J Physiol Gastrointest Liver Physiol 288: G1118-G1126, 2005.
13. Hecht G, Savkovic SD. Review article: Effector role of epithelia in inflammation-interaction with bacteria. Aliment Pharmacol Ther Suppl 3: S64-S68, 1997.
14. Holzmann K, Kohlhammer H, Schwaenen C, Wessendorf S, Kestler HA, Schwoerer A, Rau B, Radlwimmer B, Dohner H, Lichter P, Gress T, Bentz M. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes. Cancer Res 64: 4428-4433, 2004.
15. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603, 2001.
16. IARC Working Group on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Carrageenan. IARC Monogr Eval Carcinog Risks Hum 31: 79-94, 1983.
17. Isaacson PG, Du MQ. MALT lymphoma: from morphology to molecules. Nat Rev Cancer 4: 644-654, 2004.
18. Ishioka T, Kuwabara N, Oohashi Y, Wakabayashi K. Induction of colorectal tumors in rats by sulfated polysaccharides. Crit Rev Toxicol 17: 215-244, 1987.
19. Jobin C, Sartor RB. The IκB/NF-κB system: a key determinant of mucosal inflammation and protection. Am J Physiol Cell Physiol 278: C451-C462, 2000.
20. Joint European Commission on Food Additives (J.E.C.F.A.). Carrageenan and processed Eucheuma seaweed (addendum). Safety evaluation of certain food additives and contaminants. WHO Food Additive Series 48: 91-101, 2002.
21. Jung HC, Eckmann L, Yang SK, Panja A, Fierer E, Morzycka-Wroblewska E, Kagnoff MF. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 95: 55-65, 1995.
22. Kitano A, Matsumoto T, Oshitani N, Nakagawa M, Yasuda K, Watanabe Y, Tomobuchi M, Obayashi M, Tabata A, Fusushima R, Okabe H, Nakamura S, Obata A, Okawa K, Kobayashi K. Distribution and anti-inflammatory effect of mesalazine on carrageenan-induced colitis in the rabbit. Clin Exp Pharmacol Physiol 23: 305-309, 1997.
23. Kunsch C, Ruben SM, Rosen CA. Selection of optimal κB/Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol Cell Biol 12: 4412-4421, 1992.
24. Marcus R. Harmful effects of carrageenan fed to animals. Cancer Detect Prev 4: 129-134, 1981.
25. Menegazzi M, Di Paola R, Mazzon E, Muia C, Genovese T, Crissafulli C, Suzuki H, Cuzzocrea S. Hypericum perforatum attenuates the development of carrageenan-induced lung injury in mice. Free Radic Biol Med 40: 740-753, 2006.
26. Mottet KN. Carrageenan ulceration as a model for human ulcerative colitis. Lancet 2(7687): 1361, 1970.
27. Moyana TN, Lalonde JM. Carrageenan-induced intestinal injury in the rat - a model for inflammatory bowel disease. Ann Clin Lab Sci 20: 420-426, 1990.
28. 27a. Moyer MP, Manzano LA, Merriman RL, Stauffer JS, Tanzer LR. NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell Dev Biol Anim 32: 315-317, 1996.
29. Nacife VP, Soeiro MD, Araujo-Jorge TC, Castro-Faria Neto HC, Meirelles MD. Ultrastructural, immunocytochemical and flow cytometry study of mouse peritoneal cells stimulated with carrageenan. Cell Struct Funct 25: 337-350, 2000.
30. Natarajan K, Singh S, Burke TR Jr, Grunberger D, Aggarwal BB. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proc Natl Acad Sci USA 93: 9090-9095, 1996.
31. Nemeth ZH, Deitch EA, Szabo C, Hasko G. Hyperosmotic stress induces NF-κB activation and interleukin-8 production in human intestinal epithelial cells. Am J Pathol 161: 987-996, 2002.
32. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayleses TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606, 2001.
33. Onderdonk AB. The carrageenan model for experimental ulcerative colitis. Prog Clin Biol Res 186: 237-245, 1985.
34. Oohashi Y, Ishioka TT, Wakabayashi K, Kuwabara H. A study of carcinogenesis induced by degraded carrageenan arising from squamous metaplasia of the rat colorectum. Cancer Lett 14: 267-272, 1981.
35. Quivy V, Van Lint C. Regulation at multiple levels of NF-κB-mediated transactivation of protein acetylation. Biochem Pharmacol 68: 1221-1229, 2004.
36. Ruland J, Duncan GS, Elia A, del Barco Barrantes I, Nguyen L, Plyte S, Millar DG, Bouchard D, Wakeham A, Ohashi PS, Mak TW. BCL-10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell 104: 33-42, 2001.
37. Savkovic SD, Koutsouris A, Hecht GA. Activation of NF-κB in intestinal epithelial cells by enteropathogenic Escherichia coli. Am J Physiol Cell Physiol 273: C1160-C1167, 1997.
38. Tobacman JK. Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ Health Perspect 109: 983-994, 2001.
39. Tobacman JK. Toxic considerations related to ingestion of carrageenan. In: Reviews in Food and Nutrition Toxicity, edited by Preedy VR and Watson RR. New York: Taylor & Francis, 2003, p. 204-229.
40. Wakabayashi K, Inagaki T, Fujimoto Y, Fukuda Y. Induction by degraded carrageenan of colorectal tumors in rats. Cancer Lett 3: 171-176, 1978.
41. Watanabe K, Reddy BS, Wong CQ, Weisburger JH. Effect of dietary undegraded carrageenan on colon carcinogenesis in F344 rats treated with azoxymethane or methylnitrosourea. Cancer Res 38: 4427-4430, 1978.
42. Wilcox DK, Higgins J, Bertram TA. Colonic epithelial cell proliferation in a rat model of nongenotoxin-induced colonic neoplasia. Lab Invest 67: 405-411, 1992.
43. Winter CA, Risley EA, Nuss GW. Carrageenan-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 111: 544-547, 1962.